Ionis Pharmaceuticals Inc
(MEX:IONS)
MXN
1,150
(0%)
Market Cap: 229.56 Bil
Enterprise Value: 231.70 Bil
PE Ratio: 0
PB Ratio: 26.77
GF Score: 65/100 Ionis Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 19, 2026 / 12:30PM GMT
Release Date Price:
MXN1150
Luca Issi
RBC Capital Markets Inc - Analyst
Thanks, everybody. Luca Issi, Senior Biotech Analyst here at RBC Capital Markets. And today is our great privilege to have Ionis Pharmaceuticals as part of our 2026 Global Healthcare Conference. Representative of the company, we have Holly Kordasiewicz, who is the Chief Development Officer.
Holly, thanks so much for joining us. How are you doing today?
Holly Kordasiewicz
Ionis Pharmaceuticals Inc - Executive Vice President and Chief Development Officer
Great. How are you?
Questions & Answers
Luca Issi
RBC Capital Markets Inc - Analyst
Good. Yes. We have a list of questions. But maybe before we go into the specifics, it will be fantastic if you can maybe talk a little bit big picture about what progress has the organization made over the last few months and kind of most importantly, Ionis?
Holly Kordasiewicz
Ionis Pharmaceuticals Inc - Executive Vice President and Chief Development Officer
Yes, absolutely
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot